Accuray Inc. announces practice milestone using its CyberKnife system.
Accuray, Inc., a radiation oncology company based in Sunnyvalle, California, recently announced that Anova Cancer Care has performed an impressive 1,000 prostate cancer treatments using the company’s CyberKnife system. CyberKnife is a robotically-controlled radiosurgery device that delivers extremely high doses of radiation to tumors with little to no side effects. It is an alternative or complimentary option to more traditional forms of cancer treatment including radiation therapy, chemotherapy and surgical techniques.
Rick H. from Denver, one of the 1,000 patients, was recently diagnosed with prostate cancer and was featured in the release. “I lead a busy life, including owning a business, so when I learned it was a non-invasive approach which would precisely target my tumor, I knew it was the right choice for me,” said Rick.
Anova’s (former) cancer specialist Dr. Gregg Dickerson was also quoted in the release saying, “Because I can deliver precise doses of radiation, I can decrease doses to surrounding healthy tissue and minimize negative side-effects on urinary, bowel and sexual function that can reduce a patient’s quality of life.”
Anova is Colorado’s only full-time CyberKnife practice and a world leader in prostate cancer treatment.